Novel anti-IGF-IR antibodies and uses thereof

Details for Australian Patent Application No. 2005268505 (hide)

Owner Pierre Fabre Medicament

Inventors Goetsch, Liliane; Corvaia, Nathalie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005268505

PCT Pub. Number WO2006/013472

Priority 60/591,932 29.07.04 US; 0408379 29.07.04 FR

Filing date 27 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 17 November 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/18 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Murine cells, e.g. mouse cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/013472 Priority application(s): WO2006/013472

17 November 2011 Application Accepted

  Published as AU-B-2005268505

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005268540-Pipe coupling

2005268501-Polypeptide